The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Secondary prevention of vascular disease by prolonged antiplatelet treatment
Open accessAbstract
Thirty one randomised trials of antiplatelet treatment for patients with a history of transient ischaemic attack, occlusive stroke, unstable angina, or myocardial infarction were identified. Six were still in progress, and the results of the remaining 25 were reviewed. They included a total of some 29,000 patients, 3000 of whom had died. Overall, allocation to antiplatelet treatment had no apparent effect on non-vascular mortality but reduced vascular mortality by 15% (SD 4%) and non-fatal vascular events (stroke or myocardial infarction) by 30% (4%). This suggested that with good compliance these treatments might reduce vascular mortality by about one sixth, other vascular events by about a third, and total vascular events by about a quarter. There was no significant difference between the effects of the different types of antiplatelet treatment tested (300-325 mg aspirin daily, higher aspirin doses, sulphinpyrazone, or high dose aspirin with dipyridamole), nor between the effects in patients with histories of cerebral or cardiac disease. Thus antiplatelet treatment can reduce the incidence of serious vascular events by about a quarter among a wide range of patients at particular risk of occlusive vascular disease. The balance of risk and benefit, however, might be different for "primary" prevention among people at low absolute risk of occlusive disease if antiplatelet treatment produced even a small increase in the incidence of cerebral haemorrhage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
AMERY, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91783-0 · Cited by 1,476
Aspirin, Sulfinpyrazone, or Both in Unstable Angina: Results of a Canadian Multicenter Trial
Cairns, J. A., Gent, M., Singer, J., Finnie, K. J., Froggatt, G. M., Holder, D. A., Jablonsky, G., Kostuk, W. J., Melendez, L. J., Myers, M. G., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511283132201 · Cited by 1,120
A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
The Canadian Cooperative Study Group (1978) · New England Journal of Medicine · doi:10.1056/nejm197807132990201 · Cited by 957
Controlled trial of aspirin in cerebral ischemia.
Fields, W. S., Lemak, N. A., Frankowski, R. F., & Hardy, R. J. (1977) · Stroke · doi:10.1161/01.str.8.3.301 · Cited by 631
Bousser, M. G., Eschwege, E., Haguenau, M., Lefaucconnier, J. M., Thibult, N., Touboul, D., & Touboul, P. J. (1983) · Stroke · doi:10.1161/01.str.14.1.5 · Cited by 612
A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial Infarction
(1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300330019023 · Cited by 565
Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
The Steering Committee of the Physicians' Health Study Research Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180431 · Cited by 520
(1980) · Circulation · doi:10.1161/01.cir.62.3.449 · Cited by 468
Clinical pharmacology of platelet cyclooxygenase inhibition.
Patrono, C., Ciabattoni, G., Patrignani, P., Pugliese, F., Filabozzi, P., Catella, F., Davì, G., & Forni, L. (1985) · Circulation · doi:10.1161/01.cir.72.6.1177 · Cited by 454
Cited by
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
(1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250701 · Cited by 8,368
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Warlow, C. (1991) · The Lancet · doi:10.1016/0140-6736(91)92916-p · Cited by 3,237
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Self-citationFinal Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Yusuf, S., Zucker, D., Passamani, E., Peduzzi, P., Takaro, T., Fisher, L. D., Kennedy, J. W., Davis, K., Killip, T., Norris, R., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91963-1 · Cited by 2,134
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00308-5 · Cited by 1,577
Kottaridis, P. D., Gale, R. E., Frew, M. E., Harrison, G., Langabeer, S. E., Belton, A. A., Walker, H., Wheatley, K., Bowen, D. T., Burnett, A. K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1752 · Cited by 1,551
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Chen, Z.-M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04010-5 · Cited by 1,232
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
Farrell, B., Godwin, J., Richards, S., & Warlow, C. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.12.1044 · Cited by 1,203
Hass, W. K., Easton, J. D., Adams, H. P., Pryse-Phillips, W., Molony, B. A., Anderson, S., Kamm, B., & for the Ticlopidine Aspirin Stroke Study Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210804 · Cited by 1,198
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140
Aspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
Gent, M., Donald Easton, J., Hachinski, V., Panak, E., Sicurella, J., Blakely, J., Ellis, D., Harbison, J., Roberts, R., & Turpie, A. G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92327-1 · Cited by 910
Weitz, J. I., Byrne, J., Clagett, G. P., Farkouh, M. E., Porter, J. M., Sackett, D. L., Strandness, D. E., & Taylor, L. M. (1996) · Circulation · doi:10.1161/01.cir.94.11.3026 · Cited by 889
The RISC Group (1990) · The Lancet · doi:10.1016/0140-6736(90)92336-g · Cited by 781
Forest plots: trying to see the wood and the trees
Lewis, S., & Clarke, M. (2001) · BMJ · doi:10.1136/bmj.322.7300.1479 · Cited by 763
(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
(1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)92635-6 · Cited by 725
Catovsky, D., Richards, S., Matutes, E., Oscier, D., Dyer, M., Bezares, R., Pettitt, A., Hamblin, T., Milligan, D., Child, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61125-8 · Cited by 677
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Circulation · doi:10.1161/hc3801.097475 · Cited by 661
Rubenstein, L. Z., Stuck, A. E., Siu, A. L., & Wieland, D. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb05927.x · Cited by 597
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 617
Bayesian approaches to random-effects meta-analysis: a comparative study
Smith, T. C., Spiegelhalter, D. J., & Thomas, A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142408 · Cited by 568
CHALMERS, I. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26345.x · Cited by 561
The Salt Collaborative Group (1991) · The Lancet · doi:10.1016/0140-6736(91)92233-r · Cited by 553
A brief history of research synthesis
Chalmers, I., Hedges, L. V., & Cooper, H. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702025001003 · Cited by 552
(1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00150.x · Cited by 532
Epidural Analgesia Reduces Postoperative Myocardial Infarction: A Meta-Analysis
Beattie, W. S., Badner, N. H., & Choi, P. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200110000-00010 · Cited by 507
Adams, H. P., Brott, T. G., Crowell, R. M., Furlan, A. J., Gomez, C. R., Grotta, J., Helgason, C. M., Marler, J. R., Woolson, R. F., & Zivin, J. A. (1994) · Stroke · doi:10.1161/01.str.25.9.1901 · Cited by 488
Thompson, S. G., & Pocock, S. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91975-z · Cited by 487
Gunnar, R. M., Bourdillon, P. D., Dixon, D. W., Fuster, V, Karp, R. B., Kennedy, J. W., Klocke, F. J., Passamani, E. R., Pitt, B., & Rapaport, E. (1990) · Circulation · doi:10.1161/01.cir.82.2.664 · Cited by 474
Demrow, H. S., Slane, P. R., & Folts, J. D. (1995) · Circulation · doi:10.1161/01.cir.91.4.1182 · Cited by 453
Lacoste, L., Lam, J. Y. T., Hung, J., Letchacovski, G., Solymoss, C. B., & Waters, D. (1995) · Circulation · doi:10.1161/01.cir.92.11.3172 · Cited by 441
Helgason, C. M., & Wolf, P. A. (1997) · Stroke · doi:10.1161/01.str.28.7.1498 · Cited by 440
Hennekens, C. H., Dyken, M. L., & Fuster, V. (1997) · Circulation · doi:10.1161/01.cir.96.8.2751 · Cited by 435
Mitchell, C. D., Richards, S. M., Kinsey, S. E., Lilleyman, J., Vora, A., Eden, T. O. B., & the Medical Research Council Childhood Leukaemia Working Party (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05509.x · Cited by 418
Yusuf, S., Macmahon, S., Collins, R., & Peto, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91906-x · Cited by 392
Ayanian, J. Z., Hauptman, P. J., Guadagnoli, E., Antman, E. M., Pashos, C. L., & McNeil, B. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410273311707 · Cited by 386
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809153191106 · Cited by 379
Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis
Schafer, A. I. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04050.x · Cited by 367
Guidelines for the early management of patients with acute myocardial infarction
Gunnar, R. M., Bourdillon, P. D. V., Dixon, D. W., Fuster, V., Karp, R. B., Kennedy, J. W., Klocke, F. J., Passamani, E. R., Pitt, B., Rapaport, E., et al. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90575-a · Cited by 344
Pravastatin Therapy and the Risk of Stroke
White, H. D., Simes, R. J., Anderson, N. E., Hankey, G. J., Watson, J. D. G., Hunt, D., Colquhoun, D. M., Glasziou, P., MacMahon, S., Kirby, A. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430502 · Cited by 338
Long-Term Risk of First Recurrent Stroke in the Perth Community Stroke Study
Hankey, G. J., Jamrozik, K., Broadhurst, R. J., Forbes, S., Burvill, P. W., Anderson, C. S., & Stewart-Wynne, E. G. (1998) · Stroke · doi:10.1161/01.str.29.12.2491 · Cited by 335
Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials
(1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.10.861 · Cited by 328
Michels, K. B., & Yusuf, S. (1995) · Circulation · doi:10.1161/01.cir.91.2.476 · Cited by 326
Dzau, V., & Braunwald, E. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90694-d · Cited by 322
Effect of strenuous exercise on platelet activation state and reactivity.
Kestin, A. S., Ellis, P. A., Barnard, M. R., Errichetti, A., Rosner, B. A., & Michelson, A. D. (1993) · Circulation · doi:10.1161/01.cir.88.4.1502 · Cited by 313
Boersma, E., Mercado, N., Poldermans, D., Gardien, M., Vos, J., & Simoons, M. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12712-2 · Cited by 305
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Berger, A. K., Duval, S., & Krumholz, H. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00572-2 · Cited by 299
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
Roderick, P., Wilkes, H., & Meade, T. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05689.x · Cited by 293
Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.11.1095 · Cited by 290
Gaspoz, J.-M., Coxson, P. G., Goldman, P. A., Williams, L. W., Kuntz, K. M., Hunink, M. G. M., & Goldman, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200206063462309 · Cited by 290
Yusuf, S., Held, P., & Furberg, C. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90944-g · Cited by 284
Chronic Myeloid Leukemia Trialists' Collaborative Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1616 · Cited by 283
Maggioni, A. P., Franzosi, M. G., Santoro, E., White, H., Van de Werf, F., & Tognoni, G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270101 · Cited by 281
JANZON, L., BERGQVIST, D., BOBERG, J., BOBERG, M., ERIKSSON, I., LINDGÄRDE, F., & PERSSON, G. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00164.x · Cited by 276
Mickelson, J. K., Lakkis, N. M., Villarreal-Levy, G., Hughes, B. J., & Smith, C. W. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00164-7 · Cited by 268
The search for evidence of effective health promotion
Speller, V., Learmonth, A., & Harrison, D. (1997) · BMJ · doi:10.1136/bmj.315.7104.361 · Cited by 171
Metadata
- Authors
- Antiplatelet Trialists' Collaboration
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1988-01-30
- Volume
- 296
- Issue
- 6618
- Pages
- 320-331
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W4252241269
- Cited by
- 1,047
- References
- 28
- FWCI
- 73.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.